Unknown

Dataset Information

0

Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.


ABSTRACT:

Background

Hypovitaminosis D is prevalent in youth worldwide, but the safety of vitamin D at doses exceeding 200 IU/d is unknown in this age group. We assessed the safety of high doses of vitamin D(3) administered to apparently healthy schoolchildren.

Methods

To assess short-term safety, 25 subjects randomly received placebo or vitamin D(3) at doses of 14,000 IU/wk for 8 wk. To assess long-term safety, 340 subjects randomly received placebo, vitamin D(3) as 1,400 IU/wk or 14,000 IU/wk for 1 yr. Biochemical variables were monitored at 0, 2, 4, 6, and 8 wk and 8 wk off therapy in the short-term study and at 0, 6, and 12 months in the long-term study.

Results

In both the short- and long-term studies, mean serum calcium and 1,25-hydroxyvitamin levels did not change in any group. In the short-term study, mean 25-hydroxyvitamin concentrations increased from 44 (+/- 11) to 54 (+/- 19) ng/ml in the treated groups (P = 0.033). In the long-term study, mean 25-hydroxyvitamin D levels increased from 15 +/- 8 to 19 +/- 7 ng/ml (P < 0.0001) in subjects receiving 1,400 IU/wk and from 15 +/- 7 to 36 +/- 22 ng/ml (P < 0.0001) in the group receiving 14,000 IU/wk. No subject developed vitamin D intoxication.

Conclusion

Vitamin D(3) at doses equivalent to 2000 IU/d for 1 yr is safe in adolescents and results in desirable vitamin D levels.

SUBMITTER: Maalouf J 

PROVIDER: S-EPMC2729206 | biostudies-literature | 2008 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.

Maalouf Joyce J   Nabulsi Mona M   Vieth Reinhold R   Kimball Samantha S   El-Rassi Rola R   Mahfoud Ziyad Z   El-Hajj Fuleihan Ghada G  

The Journal of clinical endocrinology and metabolism 20080429 7


<h4>Background</h4>Hypovitaminosis D is prevalent in youth worldwide, but the safety of vitamin D at doses exceeding 200 IU/d is unknown in this age group. We assessed the safety of high doses of vitamin D(3) administered to apparently healthy schoolchildren.<h4>Methods</h4>To assess short-term safety, 25 subjects randomly received placebo or vitamin D(3) at doses of 14,000 IU/wk for 8 wk. To assess long-term safety, 340 subjects randomly received placebo, vitamin D(3) as 1,400 IU/wk or 14,000 I  ...[more]

Similar Datasets

| S-EPMC3001453 | biostudies-literature
| S-EPMC5537834 | biostudies-literature
| S-EPMC4979151 | biostudies-literature
| S-EPMC5992315 | biostudies-literature
| S-EPMC6446320 | biostudies-literature